Decreased amplitudes in multiple sclerosis patients with normal visual acuity:: a VEP study

被引:32
作者
Diem, R
Tschirne, A
Bähr, M
机构
[1] Univ Gottingen, Urol Klin, D-37075 Gottingen, Germany
[2] Univ Tubingen, Neurol Klin, D-72076 Tubingen, Germany
关键词
multiple sclerosis; visual evoked potentials; axonal injury; VEP amplitudes; neurodegeneration; disability progression;
D O I
10.1016/S0967-5868(02)00172-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Primary demyelination with relative preservation of axons is considered to be one pathological hallmark of multiple sclerosis (MS), a chronic inflammatory disease of the central nervous system. However, imaging and pathomorphological studies have stimulated a recent reemergence of interest in the axonal, neurodegenerative aspect of MS pathology. Axonal injury appears to be a key factor of disability and permanent neurological deficit in MS patients. In the present electrophysiological study, visual potentials evoked by pattern reversal (VEPs) were recorded in 25 MS patients with normal visual acuity and unimpaired visual functions. Compared to a control population, VEP amplitudes for two different spatial frequencies were significantly decreased. From this observation, we conclude that an underlying pathological process threatening axonal integrity may not be reliably reflected by clinical parameters due to the distinct ability of the visual system to compensate for axonal loss. Pattern VEP may thus serve as an objective tool to diagnose and to monitor axonal pathology in MS. Focal conduction block due to demyelination as a cause for reduced VEP amplitudes can not be fully excluded, but would appear less likely since latency prolongation in the MS group was moderate compared to controls. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:67 / 70
页数:4
相关论文
共 38 条
[1]
Developmental changes in NMDA receptor-mediated visual activity in the rat superior colliculus, and the effect of dark rearing [J].
Binns, KE ;
Salt, TE .
EXPERIMENTAL BRAIN RESEARCH, 1998, 120 (03) :335-344
[2]
A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis [J].
Borasio, GD ;
Robberecht, W ;
Leigh, PN ;
Emile, J ;
Guiloff, RJ ;
Jerusalem, F ;
Silani, V ;
Vos, PE ;
Wokke, JHJ ;
Dobbins, T .
NEUROLOGY, 1998, 51 (02) :583-586
[4]
Cedarbaum JM, 1998, ANN NEUROL, V44, P506
[5]
SIMULTANEOUS RECORDING OF PATTERN ELECTRORETINOGRAPHY AND VISUAL EVOKED-POTENTIALS IN MULTIPLE-SCLEROSIS - A METHOD TO SEPARATE DEMYELINATION FROM AXONAL DAMAGE TO THE OPTIC-NERVE [J].
CELESIA, GG ;
KAUFMAN, D ;
CONE, SB .
ARCHIVES OF NEUROLOGY, 1986, 43 (12) :1247-1252
[6]
Charcot JM, 1868, GAZ HOPITAUX, V41, P557
[7]
Charcot JM, 1868, GAZ HOPITAUX, V41, P566
[8]
Charcot JM, 1868, GAZ HOP PARIS, V41, P554
[9]
Cogen J, 2000, J NEUROBIOL, V45, P120, DOI 10.1002/1097-4695(20001105)45:2<120::AID-NEU6>3.0.CO
[10]
2-6